Biodesix (BDSX) Total Current Liabilities (2019 - 2026)

Biodesix (BDSX) has reported Total Current Liabilities for 8 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $14.5 million, up 8.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (up 8.81% YoY), and the FY2025 annual result was $17.4 million, up 21.79% from the prior year.
• Total Current Liabilities was $14.5 million for Q1 2026 at Biodesix, down from $17.4 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $37.4 million in Q3 2022 and troughed at $13.0 million in Q3 2024.
• Average Total Current Liabilities over 5 years is $23.2 million, with a median of $22.1 million recorded in 2023.
• Year-over-year, Total Current Liabilities jumped 84.89% in 2022 and slumped 60.3% in 2024.
• Over 5 years, Total Current Liabilities stood at $22.8 million in 2022, then soared by 46.31% to $33.4 million in 2023, then tumbled by 57.16% to $14.3 million in 2024, then grew by 21.79% to $17.4 million in 2025, then slipped by 16.9% to $14.5 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $14.5 million in Q1 2026, $17.4 million in Q4 2025, and $18.2 million in Q3 2025.